Active Ingredient: ELAFIBRANOR
Proprietary Name: IQIRVO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218860
Product Number: 001
Approval Date: Jun 10, 2024
Applicant Holder Full Name: IPSEN BIOPHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
